- Home
- CLDX vs ARCB Comparison
CLDX vs ARCB Comparison
Compare CLDX & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDX | ARCB |
|---|---|---|
| Founded | N/A | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.2B |
| IPO Year | 1995 | 1994 |
Fundamental Metrics
Financial Performance| Metric | CLDX | ARCB |
|---|---|---|
| Price | $38.90 | $135.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | $46.60 | ★ $122.75 |
| AVG Volume (30 Days) | ★ 694.0K | 223.4K |
| Earning Date | 05-04-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.38% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $12,743,000.00 | ★ $1,657,864,000.00 |
| Revenue This Year | $111.39 | $7.00 |
| Revenue Next Year | $235.85 | $5.80 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 87.78 | 12.56 |
| 52 Week Low | $22.10 | $59.43 |
| 52 Week High | $45.14 | $176.69 |
Technical Indicators
Market Signals| Indicator | CLDX | ARCB |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 45.61 |
| Support Level | $28.51 | $133.90 |
| Resistance Level | $40.30 | $142.67 |
| Average True Range (ATR) | 1.37 | 5.61 |
| MACD | -0.36 | 0.33 |
| Stochastic Oscillator | 9.94 | 41.64 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About ARCB ArcBest Corporation
ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.